Regional White Matter Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community | Cerebrovascular Disease | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.185.54. Please contact the publisher to request reinstatement.
1.
Jack CR Jr, Knopman DS, Jagust WJ,  et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.  Lancet Neurol. 2010;9(1):119-12820083042PubMedGoogle ScholarCrossref
2.
Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence.  Lancet Neurol. 2011;10(9):819-82821775213PubMedGoogle ScholarCrossref
3.
Albert MS, DeKosky ST, Dickson D,  et al.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimers Dement. 2011;7(3):270-27921514249PubMedGoogle ScholarCrossref
4.
McKhann GM, Knopman DS, Chertkow H,  et al.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimers Dement. 2011;7(3):263-26921514250PubMedGoogle ScholarCrossref
5.
Sperling RA, Aisen PS, Beckett LA,  et al.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging–Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.  Alzheimers Dement. 2011;7(3):280-29221514248PubMedGoogle ScholarCrossref
6.
Altman R, Rutledge JC. The vascular contribution to Alzheimer's disease.  Clin Sci (Lond). 2010;119(10):407-42120684749PubMedGoogle ScholarCrossref
7.
Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review.  Stroke. 1997;28(3):652-6599056627PubMedGoogle ScholarCrossref
8.
Yoshita M, Fletcher E, Harvey D,  et al.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.  Neurology. 2006;67(12):2192-219817190943PubMedGoogle ScholarCrossref
9.
Brickman AM, Honig LS, Scarmeas N,  et al.  Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease.  Arch Neurol. 2008;65(9):1202-120818779424PubMedGoogle ScholarCrossref
10.
Prins ND, van Dijk EJ, den Heijer T,  et al.  Cerebral white matter lesions and the risk of dementia.  Arch Neurol. 2004;61(10):1531-153415477506PubMedGoogle ScholarCrossref
11.
Tang MX, Cross P, Andrews H,  et al.  Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan.  Neurology. 2001;56(1):49-5611148235PubMedGoogle ScholarCrossref
12.
Brickman AM, Schupf N, Manly JJ,  et al.  Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan.  Arch Neurol. 2008;65(8):1053-106118695055PubMedGoogle ScholarCrossref
13.
Stern Y, Andrews H, Pittman J,  et al.  Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education.  Arch Neurol. 1992;49(5):453-4601580806PubMedGoogle ScholarCrossref
14.
Siedlecki KL, Manly JJ, Brickman AM, Schupf N, Tang MX, Stern Y. Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers?  Neuropsychology. 2010;24(3):402-41120438217PubMedGoogle ScholarCrossref
15.
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987
16.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.  Neurology. 1984;34(7):939-9446610841PubMedGoogle ScholarCrossref
17.
McKeith IG, Perry EK, Perry RH.Consortium on Dementia with Lewy Bodies.  Report of the second dementia with Lewy body international workshop: diagnosis and treatment.  Neurology. 1999;53(5):902-90510496243PubMedGoogle ScholarCrossref
18.
Román GC, Tatemichi TK, Erkinjuntti T,  et al.  Vascular dementia: diagnostic criteria for research studies. report of the NINDS-AIREN International Workshop.  Neurology. 1993;43(2):250-2608094895PubMedGoogle ScholarCrossref
19.
Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease.  Neurology. 2005;65(4):545-55116116114PubMedGoogle ScholarCrossref
20.
Brickman AM, Muraskin J, Zimmerman ME. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter?  Dialogues Clin Neurosci. 2009;11(2):181-19019585953PubMedGoogle Scholar
21.
Brickman AM, Sneed JR, Provenzano FA,  et al.  Quantitative approaches for assessment of white matter hyperintensities in elderly populations.  Psychiatry Res. 2011;193(2):101-10621680159PubMedGoogle ScholarCrossref
22.
Admiraal-Behloul F, Olofesen H, Van den Heuvel DM, Schmitz N, Reiber JH, Van Buchem MA. Fully automatic lobe delineation for regional white matter lesion load quantification in a large scale study.  Proc Intl Soc Mag Reson Med. 2004;11:138http://cds.ismrm.org/ismrm-2004/Files/000138.pdfGoogle Scholar
23.
Fernando MS, Simpson JE, Matthews F,  et al; MRC Cognitive Function and Ageing Neuropathology Study Group.  White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.  Stroke. 2006;37(6):1391-139816627790PubMedGoogle ScholarCrossref
24.
Gouw AA, Seewann A, van der Flier WM,  et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.  J Neurol Neurosurg Psychiatry. 2011;82(2):126-13520935330PubMedGoogle ScholarCrossref
25.
Möller HJ, Graeber MB. The case described by Alois Alzheimer in 1911: historical and conceptual perspectives based on the clinical record and neurohistological sections.  Eur Arch Psychiatry Clin Neurosci. 1998;248(3):111-1229728729PubMedGoogle ScholarCrossref
26.
Jacobs HI, Visser PJ, Van Boxtel MP,  et al.  Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent.  Neurobiol Aging. 2012;33(1):201, e1-e820739101PubMedGoogle ScholarCrossref
27.
Sveinbjornsdottir S, Sigurdsson S, Aspelund T,  et al.  Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location.  J Neurol Neurosurg Psychiatry. 2008;79(9):1002-100618270235PubMedGoogle ScholarCrossref
28.
Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?  Neurology. 2007;69(9):871-87717724289PubMedGoogle ScholarCrossref
29.
Pettersen JA, Sathiyamoorthy G, Gao FQ,  et al.  Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study.  Arch Neurol. 2008;65(6):790-79518541799PubMedGoogle ScholarCrossref
30.
Chase TN, Foster NL, Fedio P, Brooks R, Mansi L, Di Chiro G. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.  Ann Neurol. 1984;15(S1):(suppl)  S170-S1746611118PubMedGoogle ScholarCrossref
31.
Jacobs HIL, Van Boxtel MPJ, Jolles J, Verhey FRJ, Uylings HBM. Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings.  Neurosci Biobehav Rev. 2012;36(1):297-30921741401PubMedGoogle ScholarCrossref
32.
Jack CR Jr, Lowe VJ, Weigand SD,  et al; Alzheimer's Disease Neuroimaging Initiative.  Serial PiB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.  Brain. 2009;132(pt 5):1355-136519339253PubMedGoogle ScholarCrossref
33.
Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C.Medical Research Council Cognitive Function and Ageing Study.  Age, neuropathology, and dementia.  N Engl J Med. 2009;360(22):2302-230919474427PubMedGoogle ScholarCrossref
34.
Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease.  Vasc Health Risk Manag. 2007;3(2):229-23417580733PubMedGoogle ScholarCrossref
35.
DeCarli C, Massaro J, Harvey D,  et al.  Measures of brain morphology and infarction in the Framingham Heart Study: establishing what is normal.  Neurobiol Aging. 2005;26(4):491-51015653178PubMedGoogle ScholarCrossref
36.
Lopez OL, Kuller LH, Fitzpatrick A, Ives D, Becker JT, Beauchamp N. Evaluation of dementia in the cardiovascular health cognition study.  Neuroepidemiology. 2003;22(1):1-1212566948PubMedGoogle ScholarCrossref
Original Contribution
Dec 2012

Regional White Matter Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the Community

Author Affiliations

Author Affiliations: Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Drs Brickman, Manly, Stern, and Mayeux and Messrs Provenzano, Muraskin, and Apa), Gertrude H. Sergievsky Center (Drs Brickman, Manly, Blum, Stern, and Mayeux), and Departments of Neurology (Drs Brickman, Manly, Blum, Stern, and Mayeux), Psychiatry (Drs Stern and Mayeux), and Medicine (Dr Luchsinger), College of Physicians and Surgeons, and Department of Epidemiology, Mailman School of Public Health (Drs Luchsinger and Mayeux), Columbia University, New York, New York; and Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston (Dr Brown).

Arch Neurol. 2012;69(12):1621-1627. doi:10.1001/archneurol.2012.1527
Abstract

Background New-onset Alzheimer disease (AD) is often attributed to degenerative changes in the hippocampus. However, the contribution of regionally distributed small vessel cerebrovascular disease, visualized as white matter hyperintensities (WMHs) on magnetic resonance imaging, remains unclear.

Objective To determine whether regional WMHs and hippocampal volume predict incident AD in an epidemiological study.

Design A longitudinal community-based epidemiological study of older adults from northern Manhattan, New York.

Setting The Washington Heights/Inwood Columbia Aging Project.

Participants Between 2005 and 2007, 717 participants without dementia received magnetic resonance imaging scans. A mean (SD) of 40.28 (9.77) months later, 503 returned for follow-up clinical examination and 46 met criteria for incident dementia (45 with AD). Regional WMHs and relative hippocampal volumes were derived. Three Cox proportional hazards models were run to predict incident dementia, controlling for relevant variables. The first included all WMH measurements; the second included relative hippocampal volume; and the third combined the 2 measurements.

Main Outcome Measure Incident AD.

Results White matter hyperintensity volume in the parietal lobe predicted time to incident dementia (hazard ratio [HR] = 1.194; P = .03). Relative hippocampal volume did not predict incident dementia when considered alone (HR = 0.419; P = .77) or with the WMH measures included in the model (HR = 0.302; P = .70). Including hippocampal volume in the model did not notably alter the predictive utility of parietal lobe WMHs (HR = 1.197; P = .049).

Conclusions The findings highlight the regional specificity of the association of WMHs with AD. It is not clear whether parietal WMHs solely represent a marker for cerebrovascular burden or point to distinct injury compared with other regions. Future work should elucidate pathogenic mechanisms linking WMHs and AD pathology.

×